Gabapentin Tablets, USP, 600 mg, 500-count bottles, Rx only, Manufactured by: Granules India Limi...

FDA Drug Recall #D-0634-2024 — Class II — July 31, 2024

Recall Summary

Recall Number D-0634-2024
Classification Class II — Moderate risk
Date Initiated July 31, 2024
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Granules Pharmaceuticals Inc.
Location Chantilly, VA
Product Type Drugs
Quantity 11,808 500-count Bottles

Product Description

Gabapentin Tablets, USP, 600 mg, 500-count bottles, Rx only, Manufactured by: Granules India Limited Hyderabad-500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA NDC 70010-227-05

Reason for Recall

Presence of Foreign Tablets; 3 fused tablets of Metformin ER 500 mg were found in bottle of Gabapentin Tablets

Distribution Pattern

Nationwide in the USA

Lot / Code Information

Lot 1380040A, Exp. date July 31, 2025

Other Recalls from Granules Pharmaceuticals Inc.

Recall # Classification Product Date
D-0305-2026 Class II Trazodone Hydrochloride, USP, 50 mg, 100-Count ... Jan 26, 2026
D-0672-2025 Class III Dextroamphetamine Saccharate, Amphetamine Aspar... Aug 28, 2025
D-0670-2025 Class III Dextroamphetamine Saccharate, Amphetamine Aspar... Aug 28, 2025
D-0669-2025 Class III Dextroamphetamine Saccharate, Amphetamine Aspar... Aug 28, 2025
D-0671-2025 Class III Dextroamphetamine Saccharate, Amphetamine Aspar... Aug 28, 2025

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.